Squarepoint’s Radius Health, Inc. RDUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-52,211
Closed -$541K 3648
2022
Q2
$541K Sell
52,211
-84,255
-62% -$627K ﹤0.01% 1974
2022
Q1
$1.21M Sell
136,466
-168,402
-55% -$1.28M 0.01% 1471
2021
Q4
$2.11M Buy
304,868
+243,916
+400% +$3.58M 0.01% 1226
2021
Q3
$756K Buy
60,952
+10,695
+21% +$154K ﹤0.01% 1730
2021
Q2
$917K Buy
+50,257
New +$999K ﹤0.01% 1694
2020
Q4
Sell
-39,145
Closed -$444K 3390
2020
Q3
$444K Buy
+39,145
New +$484K 0.01% 1525
2020
Q2
Sell
-47,847
Closed -$622K 2623
2020
Q1
$622K Sell
47,847
-31,031
-39% -$553K 0.02% 924
2019
Q4
$1.59M Buy
+78,878
New +$1.92M 0.01% 1048
2019
Q2
Sell
-62,257
Closed -$1.24M 2761
2019
Q1
$1.24M Buy
62,257
+8,255
+15% +$151K 0.01% 991
2018
Q4
$890K Buy
54,002
+179
+0.3% +$3.01K 0.01% 974
2018
Q3
$958K Buy
53,823
+31,423
+140% +$711K 0.01% 1014
2018
Q2
$660K Buy
+22,400
New +$708K 0.01% 1060
2018
Q1
Sell
-15,159
Closed -$482K 2302
2017
Q4
$482K Buy
+15,159
New +$476K 0.01% 1234
2017
Q2
Sell
-11,844
Closed -$458K 1901
2017
Q1
$458K Buy
+11,844
New +$497K 0.01% 894

Other funds holding RDUS

Squarepoint's RDUS Position: Q3 2022 in Review

Squarepoint sold out of Radius Health, Inc. (RDUS) in Q3 2022, closing a stake of 52,211 shares — an estimated $541K sold.

Squarepoint first reported a position in RDUS in Q1 2017 and held it in 14 quarters. The position peaked at $2.11M in Q4 2021. 1 fund tracked by Wall St. Rank holds RDUS as of Q3 2022.

  • Squarepoint reported no remaining Radius Health, Inc. position as of Q3 2022 after selling out during the quarter.
  • Squarepoint sold 52,211 Radius Health, Inc. shares in Q3 2022, an estimated $541K.
  • Squarepoint first reported a position in Radius Health, Inc. in Q1 2017 and held it in 14 quarters.
  • Squarepoint's Radius Health, Inc. position peaked at $2.11M in Q4 2021.
  • 1 fund tracked by Wall St. Rank held Radius Health, Inc. as of Q3 2022.

Based on Squarepoint's 13F filing for Q3 2022, filed 14 Nov 2022.